245 related articles for article (PubMed ID: 33205966)
21. Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis.
Yan F; Polk DB
Front Immunol; 2020; 11():1428. PubMed ID: 32719681
[TBL] [Abstract][Full Text] [Related]
22. Combinatory biotechnological intervention for gut microbiota.
Khangwal I; Shukla P
Appl Microbiol Biotechnol; 2019 May; 103(9):3615-3625. PubMed ID: 30847544
[TBL] [Abstract][Full Text] [Related]
23. Synthetic biology in probiotic lactic acid bacteria: At the frontier of living therapeutics.
Mays ZJ; Nair NU
Curr Opin Biotechnol; 2018 Oct; 53():224-231. PubMed ID: 29550614
[TBL] [Abstract][Full Text] [Related]
24. Modulation of Gut Microbiota for Health by Current and Next-Generation Probiotics.
Satokari R
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443276
[TBL] [Abstract][Full Text] [Related]
25. Overview of the rules of the microbial engagement in the gut microbiome: a step towards microbiome therapeutics.
Yadav M; Chauhan NS
J Appl Microbiol; 2021 May; 130(5):1425-1441. PubMed ID: 33022786
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
Fong W; Li Q; Yu J
Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
[TBL] [Abstract][Full Text] [Related]
27. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.
Hiippala K; Jouhten H; Ronkainen A; Hartikainen A; Kainulainen V; Jalanka J; Satokari R
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060606
[TBL] [Abstract][Full Text] [Related]
28. Synthetic Bacteria for Therapeutics.
Vo P; Lee HM; Na D
J Microbiol Biotechnol; 2019 Jun; 29(6):845-855. PubMed ID: 31216840
[TBL] [Abstract][Full Text] [Related]
29. Dietary Interventions to Modulate the Gut Microbiome-How Far Away Are We From Precision Medicine.
De Filippis F; Vitaglione P; Cuomo R; Berni Canani R; Ercolini D
Inflamm Bowel Dis; 2018 Sep; 24(10):2142-2154. PubMed ID: 29668914
[TBL] [Abstract][Full Text] [Related]
30. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.
Hwang IY; Koh E; Kim HR; Yew WS; Chang MW
Drug Resist Updat; 2016 Jul; 27():59-71. PubMed ID: 27449598
[TBL] [Abstract][Full Text] [Related]
31. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox.
Pedrolli DB; Ribeiro NV; Squizato PN; de Jesus VN; Cozetto DA;
Trends Biotechnol; 2019 Jan; 37(1):100-115. PubMed ID: 30318171
[TBL] [Abstract][Full Text] [Related]
32. Recoding the metagenome: microbiome engineering in situ.
Whitfill T; Oh J
Curr Opin Microbiol; 2019 Aug; 50():28-34. PubMed ID: 31622928
[TBL] [Abstract][Full Text] [Related]
33. Prebiotics: tools to manipulate the gut microbiome and metabolome.
Enam F; Mansell TJ
J Ind Microbiol Biotechnol; 2019 Oct; 46(9-10):1445-1459. PubMed ID: 31201649
[TBL] [Abstract][Full Text] [Related]
34. Engineering Diagnostic and Therapeutic Gut Bacteria.
Landry BP; Tabor JJ
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
[TBL] [Abstract][Full Text] [Related]
35. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
Schiattarella GG; Sannino A; Esposito G; Perrino C
Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
[TBL] [Abstract][Full Text] [Related]
36. The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.
Sanchez-Rodriguez E; Egea-Zorrilla A; Plaza-Díaz J; Aragón-Vela J; Muñoz-Quezada S; Tercedor-Sánchez L; Abadia-Molina F
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32110880
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
Kang Y; Pan W; Cai Y
Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
[TBL] [Abstract][Full Text] [Related]
38. A quantitative model for metabolic intervention using gut microbes.
Mays ZJS; Nair NU
Biotechnol Prog; 2021 Sep; 37(5):e3125. PubMed ID: 33426814
[TBL] [Abstract][Full Text] [Related]
39. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
[TBL] [Abstract][Full Text] [Related]
40. Altered gut microbiota in RA: implications for treatment.
Kang Y; Cai Y; Zhang X; Kong X; Su J
Z Rheumatol; 2017 Jun; 76(5):451-457. PubMed ID: 27909795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
